Full video transcriptClick to expand
Auto-generated transcript of @tiana.prime's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00When it comes to slanking simacs it is actually a lot more efficient and effective if you use it
- 0:05intranasily rather than injecting it. When you're injecting it a lot of the dose that you're actually
- 0:10taking is getting broken down by enzymes and it's not going straight to the brain because it has to
- 0:15bust the blood brain barrier. When you're taking it as a nasal spray it's going to go straight to
- 0:21the brain. It bypasses the blood brain barrier and it hits you within a few minutes. So the peptide
- 0:26is going to be a lot more effective and a lot more efficient and it's just going to be more
- 0:31consistent. One thing you do need to be aware of though is the quality and the sterility of the
- 0:37actual nasal spray. So if you want me to break down how to keep your nasal sprays sterile and safe to
- 0:42yours then let me know.
Peptide therapy TikTok claims: what the science actually supports
Quick answer
Selank is a synthetic heptapeptide analog of tuftsin developed in Russia and studied primarily via intranasal administration for anxiolytic and nootropic effects. The intranasal route for CNS-targeting peptides is supported by olfactory nerve transport data, but human pharmacokinetic comparisons between intranasal and subcutaneous selank do not currently exist in peer-reviewed literature. Compounded intranasal peptide formulations are not FDA-approved and carry formulation-specific risks including microbial contamination and concentration variability.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide therapy TikTok claims: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
Peptide therapy TikTok claims: what the science actually supports should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide therapy TikTok claims: what the science actually supports" from T. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Selank is a synthetic heptapeptide analog of tuftsin developed in Russia and studied primarily via intranasal administration for anxiolytic and nootropic effects.
The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7631825606388272404." In this clip, the useful excerpt is: "When it comes to slanking simacs it is actually a lot more efficient and effective if you use it intranasily rather than injecting it." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Selank is a synthetic heptapeptide analog of tuftsin developed in Russia and studied primarily via intranasal administration for anxiolytic and nootropic effects.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Selank is a synthetic heptapeptide analog of tuftsin developed in Russia and studied primarily via intranasal administration for anxiolytic and nootropic effects. The intranasal route for CNS-targeting peptides is supported by olfactory nerve transport data, but human pharmacokinetic comparisons between intranasal and subcutaneous selank do not currently exist in peer-reviewed literature. Compounded intranasal peptide formulations are not FDA-approved and carry formulation-specific risks including microbial contamination and concentration variability.
- Selank was specifically developed and studied using intranasal administration in Russian clinical research, making this a legitimate delivery route rather than a workaround.
- The olfactory-trigeminal nerve pathway does allow some peptides to reach the CNS without passing through blood, but it is a partial bypass, not a complete one, as Dhuria et al. (2010) documented.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Selank was specifically developed and studied using intranasal administration in Russian clinical research, making this a legitimate delivery route rather than a workaround.
- The olfactory-trigeminal nerve pathway does allow some peptides to reach the CNS without passing through blood, but it is a partial bypass, not a complete one, as Dhuria et al. (2010) documented.
- Plasma peptidases are a real obstacle for short peptides administered systemically, but subcutaneous injection also avoids first-pass liver metabolism, so the comparison is not as simple as the video suggests.
- No published human trial has directly compared intranasal vs. subcutaneous selank on pharmacokinetic or efficacy measures. The superiority claim is plausible but not proven.
- Compounded intranasal peptide sprays are not FDA-regulated products. Sterility, concentration accuracy, and preservative compatibility vary by pharmacy and cannot be assumed.
- Anyone using selank or semax in any form should be doing so under a licensed provider's supervision, not based on social media delivery-route advice.
- Onset-of-effect timing for intranasal neuropeptides varies significantly between individuals due to mucosal differences, mucociliary clearance rates, and formulation variables.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @tiana.prime actually say?
The creator argues that intranasal delivery of selank and semax is "a lot more efficient and effective" than injection because injection loses dose to enzymatic breakdown and still faces the blood-brain barrier. Nasal spray, they claim, "bypasses the blood brain barrier and hits you within a few minutes." The core argument is that the olfactory route gives you better, faster brain delivery with more consistency.
The framing is confident and mechanistic, which tends to land well on TikTok. But confident and mechanistic is exactly the kind of framing that deserves a closer look.
Does the science back this up?
Partially, yes. The intranasal route for peptides with CNS targets is genuinely supported by research. It is not just broscience. Studies have shown that small neuropeptides can travel along olfactory and trigeminal nerve pathways directly into the CNS, sidestepping systemic circulation entirely.
Dhuria, Hanson, and Frey (2010, Journal of Pharmaceutical Sciences) documented this pathway in detail, showing that intranasal delivery can achieve meaningful CNS concentrations for peptides that struggle to cross the blood-brain barrier via blood. Selank is a heptapeptide (seven amino acids), which is small enough that this pathway is plausible. The claim about enzymatic degradation during injection is also real: peptidases in plasma do break down short peptides before they reach target tissues. That part checks out. Where things get slippery is in how absolute the creator makes it sound.
What did they get wrong (or right)?
They got the direction right but overstated the certainty. Saying intranasal delivery "bypasses" the blood-brain barrier is not quite accurate as a blanket statement. What actually happens is more nuanced: some fraction of an intranasally administered peptide does reach the CNS via the olfactory epithelium, but a significant portion still gets absorbed systemically through nasal vasculature and faces the same degradation issues they described for injection.
Craft, Bhatt, and others have noted that intranasal bioavailability studies show high variability depending on formulation, mucosal absorption rates, and mucociliary clearance (Craft et al., 2012, Alzheimer's and Dementia). There is also no published head-to-head pharmacokinetic trial comparing intranasal selank to subcutaneous selank in humans. The Russian clinical literature on selank (Semenova et al., 2010, Bulletin of Experimental Biology and Medicine) studied it intranasally, which does suggest this was the intended delivery route, but that does not prove injection is inferior. The creator is making a comparative claim without comparative data.
What should you actually know?
Intranasal delivery of neuropeptides is a legitimate area of research, and selank was specifically developed and studied using intranasal administration. That is worth knowing. The claim that it "hits you within a few minutes" is plausible given the direct nerve pathway, though individual response varies considerably.
What the creator skips is important context: compounded nasal sprays are not regulated products. Sterility, concentration accuracy, and preservative choice all affect both safety and efficacy. The creator briefly nods to sterility at the end, which is the right instinct. Beyond sterility, anyone considering any peptide delivery method should be doing so under the supervision of a licensed provider who can review their full health picture, not based on a TikTok video. Peptide therapy sits in a regulatory gray zone, and "more efficient" does not mean "safe for everyone."
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
T · TikTok creator
10.4K views on this video
Peptide therapy TikTok claims: what the science actually supports
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about selank was specifically developed?
Selank was specifically developed and studied using intranasal administration in Russian clinical research, making this a legitimate delivery route rather than a workaround.
What does the video say about the olfactory-trigeminal nerve pathway does allow some peptides to reach?
The olfactory-trigeminal nerve pathway does allow some peptides to reach the CNS without passing through blood, but it is a partial bypass, not a complete one, as Dhuria et al. (2010) documented.
What does the video say about plasma peptidases?
Plasma peptidases are a real obstacle for short peptides administered systemically, but subcutaneous injection also avoids first-pass liver metabolism, so the comparison is not as simple as the video suggests.
What does the video say about no published human trial has directly compared intranasal vs. subcutaneous?
No published human trial has directly compared intranasal vs. subcutaneous selank on pharmacokinetic or efficacy measures. The superiority claim is plausible but not proven.
What does the video say about compounded intranasal peptide sprays?
Compounded intranasal peptide sprays are not FDA-regulated products. Sterility, concentration accuracy, and preservative compatibility vary by pharmacy and cannot be assumed.
What does the video say about anyone using selank?
Anyone using selank or semax in any form should be doing so under a licensed provider's supervision, not based on social media delivery-route advice.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by T, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.